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Effect of glucose and pyruvate in acidic and non-acidic peritoneal
dialysis fluids on leukocytes cell functions. A new peritoneal dialysate
containing pyruvate anions has been tested for its effects on cell functions
and compared with conventional lactate and bicarbonate based solutions.
The dialysate has a final pH of 5.4 to 5.6 and is composed of 1.36 to 3.86%
glucose-monohydrate, 132 mmol/liter sodium, 1.75 mmol/liter calcium,
0.75 mmollliter magnesium, 102 mmol/liter chloride and 35 mmol/liter
pyruvate. For cytotoxicity testing peritoneal macrophages and peripheral
blood mononuclear cells (PBMC) were exposed to conventional lactate
dialysate, pyruvate dialysate, bicarbonate dialysate and a control medium
RPMI 1640 (Biochrom KG, Berlin, Germany), followed by activation with
different bacterial stimuli. In addition, the study further investigated the
effect of varying glucose concentration in the different dialysates ranging
from 0 to 3.86% and pH changes between 5.2 and 7.4 on the cytotoxicity
effect on the selected cells. Mononuclear cells exposed to pyruvate-based
dialysate before stimulation with endotoxin exhibited a tumor necrosis
factor (TNF)-mRNA signal comparable to those of cells exposed to
RPMI. In contrast, exposure to lactate-based dialysate completely inhib-
ited TNF-mRNA synthesis. In addition, cytokine synthesis in macrophages
and PBMCs after exposure to pyruvate was less inhibited when compared
to the corresponding levels measured after exposure to lactate. The
chemotactic response of polymorphonuclear cells and °2 generation in
all tested cell types after exposure to pyruvate was found not to be
inhibited, whereas a complete inhibition was observed after exposure to
lactate. The results demonstrate that cytotoxicity effects of peritoneal
dialysate on cell lines can be minimized by using a new dialysate
formulation containing pyruvate anions instead of lactate.
13]. Other dialysate components which may separately or syner-
gistically act with glucose to induce cytotoxicity are the low pH
[14] and the presence of lactate anions (35 mmol!liter) in racenlic
mixtures containing both the D- and L-forms [14].
To avoid these toxic effects of dialysate chemicals, newly
formulated dialysis solutions containing peptides [15, 16], glycerol
[17], or glucose polymers as osmotic agents [18, 19], or bicarbon-
ate instead of lactate, have been proposed [20]. Recently, we
demonstrated that peritoneal dialysis solution buffered with pyru-
vate had less negative effects on the peritoneal cell function than
lactate based dialysates [21, 22]. This study further analyzed the
effects of pyruvate on the cell functions by varying the pH, the
glucose concentration, and finally by combining pyruvate and
bicarbonate. To test whether the mixture of pyruvate with varying
levels of glucose at different pHs or in the combination with
bicarbonate interferes with the leukocyte response to bacterial
pathogens, we challenged dialysate exposed cells with different
bacterial agents. Human peripheral blood mononuclear cells and
human peritoneal macrophages were tested for chemotactic re-
sponse, metabolic activity and cytokine release after exposition to
conventional lactate dialysate, and the new pyruvate dialysate.
Methods
Preparations of test solutions
Lactate-based peritoneal dialysate solutions have acute delete-
rious effects on peritoneal macrophages and granulocytes possibly
leading to impaired host defense and increased incidence of
peritonitis [1, 2]. In this respect, it has been demonstrated that
commercially available glucose and lactate based peritoneal dia-
lysates reduce the capacity of leukocytes for chemotaxis, bacterial
killing [3—6], and production of monokines [7, 8]. In addition,
utilization of these standard dialysate solutions has been shown to
cause an inhibition of mesothelial cell proliferation [9, 10] result-
ing in peritoneal membrane damage in the chronic situation.
Toxic properties of CAPD solutions appear to be related to high
glucose concentrations (1.36 to 3.86%), as demonstrated in pre-
vious studies that glucose inhibits cell proliferation and RNA
synthesis, induces DNA damage, and accelerates cell death [10—
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The composition of the pyruvate peritoneal dialysate was
glucose-monohydrate 1.36—3.86% (wt/vol), sodium 132 mmol/
liter, calcium 1.75 mmollliter, magnesium 0.75 mmol/liter, chlo-
ride 102 mmol/liter, and pyruvate 35 mmol/liter. The pH of the
pyruvate dialysate was adjusted to between 5.8 and 5.4 using
pyruvic acid (Sigma Chemicals, Poole, Dorset, UK). The compo-
sition of the lactate based peritoneal dialysate was glucose-
monohydrate 1.36—3.86% (wt/vol), sodium 132 mmol/liter, cal-
cium 1.75 mmol/liter, magnesium 0.75 mmol/liter, chloride 102
mmol/liter, and lactate 35 mmol/liter. The pH of the lactate
dialysate was adjusted to between 5.4 and 5.8 using acetic acid.
The solutions without pyruvate or lactate were also prepared as
described above, with an inclusion of 35 mmol bicarbonate
instead. For testing in acidic conditions, the pH of these solutions
were adjusted from 5.4 to 5.8 with acetic acid. The osmolality of
all glucose containing solutions was approximately 340 mOsmfkg
(1.36% glucose) and 480 mOsm/kg (3.86% glucose), respectively.
Cell isolation and preparations
Polymorphonuclear cells (PMN) from peripheral blood of
healthy donors were isolated from 20 ml blood by dextran
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sedimentation (6% dextran, molecular wt 70,000) followed by
Ficoll (Pharmacia, Upsala, Sweden) density gradient centrifuga-
tion (160 g for 35 mm at 4°C). The PMN were counted in a
Neubauer chamber and resuspended in Hank's balanced salt
solution, HBSS (Biochrom, Berlin, Germany) at 5 X 106 cells/ml.
Preparations contained > 95% PMN as determined by light
microscopy. The PMN cell viability was determined by Trypan
blue exclusion test and always exceeded 95%.
Peripheral blood mononuclear cells from healthy donors
(PBMC) were separated from heparinized blood samples (10
lU/mI) by density gradient centrifugation over Ficoll-Hypaque
(Pharmacia). The phase containing PBMC was collected and
washed with saline (3 times), counted, resuspended in RPMI
(Biochrom, Berlin, Germany; RPMI is the medium formulation
from the "Roosevelt Park Memorial Institute") containing 1%
pyrogen-free bovine serum albumin (BSA), and prepared imme-
diately for cytokine tests. The pyrogen tests were assayed by use of
LAL Mallinckrodt (Limulus Amebocyte Lysate test) from Sangtec
Diagnostica (Germany). The test sensitivity was 6 pg/mI LPS
(lipopolysaccharide) as determined from standard LPS included
in the kit (FDA-Reference-Endotoxin from E. coli-055:B5 from
Sigma, Deisenhofen, Germany).
Macrophages (PM) were separated from peritoneal effluent
stored on ice during collection and after a four hour dwell of a 2
liter infusion of 0.9% saline in seven CAPD patients without
peritonitis for a duration not less than six months. The entire
saline drainage volume ranging from I to 2 liters was centrifuged
at 300 X g for 30 minutes. The total drainage volume yielded 5 X
io to 6 X 106 cells. The average cell composition was 80%
macrophages, 14% lymphocytes, 4% neutrophils, and 2% eosin-
ophils. The macrophages were not pooled for the various studies.
Macrophages isolated from each individual patient's peritoneal
effluent, were used separately for the complete test including the
control and the formulated solutions.
Preparation of the bacterial toxins
Lipopolysaccharide (LPS) from E. coli (055 B5) and staphylo-
coccal enterotoxin (SEB) were purchased from Sigma. Exotoxin A
was purified from Pseudomonas aeruginosa strain PA 103 accord-
ing to Liu [23]. The purification of exotoxin was performed by
three chromatographic steps according to the method described
by Leppla [241. After the three chromatographic steps on batch
DEAE-Sepharose (Pharmacia-LKB), DEAE-Sepharose and hy-
droxyapatite (Bio-Rad Laboratories GmbH, MUnchen, Germa-
ny), the final preparation was concentrated by precipitation with
ammonium sulfate and dialyzed against a buffer [0.01 mol/liter
Tris(hydroxymethyl)aminomethane (Tris)-hydrochloride, pH 8.11.
The purity of exotoxin A was assessed with SDS-PAGE clectro-
phoresis and Western blotting using a commercially available
polyclonal goat anti-exotoxin A (List Biological Lab, Inc., Camp-
bell, CA, USA).
Chemotaxis measurement
Chemotaxis of peripheral neutrophils (PMN) was performed
after a five minute exposure with different solutions. For evalua-
tion of the chemotactic response, the migration distance of cells
under agarose in tissue culture dishes was measured as described
by Nelson and Herron [251. Separated neutrophils were resus-
pended in Hanks' balanced salt solution (HBSS) and centrifuged
at 500 X g for eight minutes. The cell pellet was resuspended in
HBSS, evaluated for cell number and cell viability and diluted to
3 x iO neutrophils per ml. The center well of each dish was filled
with 10 jxl of the chemotactic fMLP (N-formyl-Met-Leu-Phe)
sample (10 mol). Samples of 10 jid containing 3 x i0 neutro-
phils were filled in the outer wells. Agarose plates were incubated
for two hours at 37°C in a humidified CO2 (5%) incubator to allow
cells to migrate. The cells were fixed with formaldehyde (37%) for
30 minutes and decanted, the agarose was removed from the
culture, and the cells were then stained with May-Grunwald's
solution. The potency of the chemotaxis was scored by the
measurement of the effective migration distance: cells migrate
towards the chemotactic gradient of the fMLP sample (distance
X) and the control medium random migration distance (Y), X-Y
represented the effective migration towards the chemotactic sam-
plc.
Superoxide anion (02-) determination
Peripheral blood mononuclear cells (PBMC), peritoneal mac-
rophages or peripheral neutrophils (PMN) were incubated for five
minutes exposure with different test solutions (RPMI solution,
pyruvate dialysate, and lactate dialysate). After the initial incuba-
tion with the different test solutions the cells were washed twice
with phosphate buffer (PBS) containing 10 jig/mI glucose, and the
cell suspensions were further incubated at 37°C for 15 minutes in
PBS buffer containing opsonized zymosan (5 x 106 PMN; 0.5 ml
PBS; 0.5 ml opsonized zymosan, in 0.25 ml cytochrome C solution;
0.1 ml pooled human serum) as the stimulant. Superoxide dis-
mutase inhibitable 02 radical formation was determined by the
reduction of cytochrome C at 546 nm in a Beckman spectral
photometer. The sensitivity of the system was drawn to -0.O5
nmol/liter 02.
Cytokine measurements
Before stimulation, cells were exposed to test solutions for a
period of 5, 15 and 30 minutes. PBMC and PMN were resus-
pended in sterile RPMI (Biochrom, Berlin; Germany) buffered
with 20 mrvi HEPES (Gibco-BRL, Eggenstein, Germany) to pH
7.4, and supplemented with 1% bovine serum albumin (BSA), 100
U/mI penicillin, 100 j.tg/ml streptomycin, and 2 m of t-glutamine.
Cell suspensions were adjusted to 2.5 x 106/ml (PBMC) and 0.5 x
106/ml (PMN). The total volume of each well was adjusted to 1 ml
with RPM! and different stimuli were used in the following
concentrations: I ng/ml concentration LPS (E. coli 055; B5; Sigma
Chemical Co.), exotoxin A (5 ng/ml), and enterotoxin B (5 ng/ml).
The cells were incubated in 24-well culture plates (Nunc, Rosk-
ilde, Denmark) in a 5% CO, atmosphere at 37°C for 24 hours. For
the ELISA measurements (Biermann, Bad Nauheim, Germany;),
cells were then lysed by repeated freezing and the supernatants
were stored frozen at —70°C until assayed for interleukin ibeta
(IL-lp), tumor necrosis factor alpha (TNF-a) and interleukin 6
(lL-6). The results of the assays should distinguish between cell
associated and extraccllular cytokine content.
The extraction of the messenger RNA was performed by the
RNAzo1 method [25] using 0.5 ml RNAzol (Peasel and Lorei,
Germany) for 2.5 X 106. RNA was reverse transcribed into eDNA
with M-MLV (Moloney murine leukemia virus) reverse transcrip-
tase (Gibco-BRL Life Technologies Ltd.), using the random
hcxamers method as previously described [25]. The reaction
mixture contained 1 id of random hexamers (100 jim; Pharmacia
Biosystems Ltd, Milton Keynes, UK), 5 .d dNTPs (2.5 j.tm; Gibco
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BRL Life Technologies Ltd), 2 xI of 10 X PCR-Buffer (100
mmol/liter Tris/HCI, 500 mmol/liter KCI, 15 mmol/liter MgCl2
and 0.01% wtlvol gelatin), 2 jxl of D1TF (0.2 M, Gibco BRL Life
Technologies), 1 1.d RNAase inhibitor (Promega), 1 xl of M-MLV
Superscript reverse transcriptase (200 units, Gihco BRL, Life
Technologies, Ltd.) and 1 xg of total RNA. The primers used for
a-actin and TNF-a were synthesized according to published
sequences [25, 26]. PCR amplification was performed in a total
volume of 50 1u1 containing 2 jxl of reverse transcription product
and 48 l of a mixture of 36.25 xl H20, 1.25 jtl of 5'-primer (20
sm), 1.25 pJ of 3'-primer (20 jLm), 4 x1 of dNTPs, 5 d of 10 X
PCR buffer and 0.25 tl of Taq polymerase (2.5 U; Amplitage, ILS
Ltd., London, UK). PCR was performed from 24 cycles to 32
cycles in four steps consisting of two cycles each. PCR was
performed for cs-actin (control) and for TNF-cs. One-tenth of the
PCR reaction products were separated by electrophoresis (Bio-
Rad Laboratories GmbH, Krefeld, Germany) on 1.5% agarose
gels (Flowgen Instruments Ltd, Sittinghourne, UK) and stained
with ethidium bromide (Sigma Chemicals). As a control, equal
amounts of RNA were used for the amplification and expression
of the a-actin mRNA. The gels were then photographed by UV
light.
Effects of high glucose concentrations on cell cytotoxicity of
dialysate solutions
The effects of high glucose concentrations in mixtures contain-
ing pyruvate-based dialysate solutions or in combinations involv-
ing bicarbonate and pyruvate were later investigated in an effort to
establish a possible improvement over the conventional peritoneal
dialysates. The experiments were designed to compare the effects
of different dialysis formulations on selected aspects of cell
functions. The formulations tested were as follows: (1) lactate (35
mmol/liter, pH 5.2, 3.86% glucose), (2) pyruvate (35 mmol/liter,
pH 5.2, glucose 3.86%), (3) bicarbonate (35 mmol/liter, pH 7.4,
3.86% glucose), (4) bicarhonate-pyruvate combination (30 mmol/
liter bicarbonate, 10 mmol/liter pyruvate, pH 7.4, 3.86% glucose),
(5) bicarbonate-lactate combination (30 mmol/liter bicarbonate,
10 mmol/liter lactate, pH 7.4, 3.86% glucose. The following
parameters were investigated: (1) 02 free radicals generation in
PBMC, peritoneal macrophages, and granulocytes; and (2) IL-lp
generation in PBMC and in peritoneal macrophages.
Statistical analysis
Statistical significance was assessed by the Wilcoxon Signed
Ranks test using the Statview 512' package version 1.01 (Brain-
Power, Inc USA; Apple Macintosh version). Significances be-
tween variables were reported at 95% confidence intervals, that is,
P < 0,05.
Results
Oxygen free radicals production and chemotactic response
To investigate the effect of CAPD solution containing pyruvate
anions versus CAPD solution containing lactate anions, chemotaxis
of granulocytes and 02 production in peritoneal macrophages,
peripheral blood mononuclear cells, and peripheral granulocytes
were investigated. As shown in Figure 1, the levels of 02
generation in granulocytes, peripheral mononuclear cells, and
peritoneal macrophages after five minutes exposure to pyruvate
dialysate were in the same range as those observed in cells
exposed to RPMJ, whereas a complete inhibition was found in
cells exposed to the conventional lactate dialysate (P < 0.01;
lactate vs. RPM!). Pyruvate dialysate and lactate dialysate were
compared by measuring 02 release. Granulocytes released ap-
proximately 40 times (P < 0.001; pyruvate vs. lactate), activated
peritoneal macrophages nearly 20 times (P < 0.01; pyruvate vs.
lactate), and activated peripheral blood monocytes six times (P <
0.001; pyruvate vs. lactate) more 02 when exposed to pyruvate as
opposed to lactate dialysate.
The chemotactic migration of peripheral granulocytes exposed
to pyruvate dialysate was 10.7 0.27 mm (mean SD), approx-
imately in the same range as that of peripheral granulocytes after
exposure to RPMI (12.5 0.55 mm). In contrast, chemotaxis of
peripheral granulocytes exposed to lactate dialysate was not
detectable in all experiments.
Cytokine reactions
As shown in Figure 2, the incubation of peripheral blood
mononuclear cells with lactate dialysate totally blocked the spon-
taneous transcription of TNF-a mRNA. The cells exposed to
pyruvate dialysate, however, showed a TNF-a mRNA signal
similar to that observed after exposure to RPMI control medium.
After one hour stimulation with LPS, there was a marked increase
in TNF-a mRNA of cells exposed to the pyruvate dialysate and
RPMI whereas the lactate exposed cells still did not produce the
TNF-a transcript.
In the investigations of cytokine synthesis at the intracellular
and extracellular levels by peripheral mononuclear cells initiated
by stimulation with different bacterial toxins (Fig. 3), measure-
ments of IL-I, TNF-, and IL-6 synthesis in the cell supernatant
confirmed the PCR results and demonstrated that pyruvate
dialysate has limited inhibitory effects at the level of cytokine
synthesis. After exposure of peripheral blood mononuclear cells
to pyruvate-hased solutions, all tested bacterial stimuli induced a
generation of TNF-a, IL-1f3 and IL-6, but at an average level of
30% less than the RPM! exposed cells. The cytokine synthesis in
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Fig. 1. Zymosan stimulated 02- production from peripheral blood mono-
nuclear cells (PBMC), peritoneal macrophages and peripheral neutrophils
(PMN) following five minutes exposition with different solutions (N 7;
mean SD): (fl) RPMI solution, (%) pyruvate dialysate, and ( lactate
dialysate. The glucose concentration in both pyruvate and lactate dialy-
sates was 1.36% (wt/vol) and the pH was between 5.4 and 5.6. Significant
differences in 02 production were observed between the control and
pyruvate as compared to lactate-based dialysates for peripheral monocytes
(P < 0.01), granulocytes (P < 0.001) and peritoneal macrophages (P <
0.01).
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Fig. 2. Ethidium bromide staining of 2% agarose gel of TNF-u/RWA from
peripheral blood mononuclear cells after one hour stimulation with LPS (5
ng/ml). Before endotoxin stimulation the monocytes were exposed for 15
minutes to RPMI, pyruvate and lactate-based dialysates. The glucose
concentration in both pyruvate and lactate-based dialysates was 1.36% and
the ph was between 5.4 and 5.6. Lane 0, DNA molecular weight marker;
lane Ito 5, RPMI-exposed (negative control) at 24, 26, 28, 30, and 32 PCR
cycles; lane 6 to it), pyruvate-exposed and LPS-stimulated at 24, 26, 28, 30,
and 32 PCR cycles; lane II to 15, lactate-exposed and LPS-stimulated at
24, 26, 28, 30, and 32 PCR cycles; lane 16 to 20, RPMT-exposed and
LPS-stimulated at 24, 26, 28, 30 and 32 PCR cycles.
Fig. 3. Total cell associated cytokines (A, TNF-a; B, IL-]; C, IL-6) in
peripheral blood mononuclear cells after 24 hours stimulation with LPS,
pseudomonas exotoxin A (5 ng/ml), and staphylococcal enterotoxin (5
,ig/niI). Before bacterial toxin stimulation the monocytes were exposed for
15 minutes to different solutions (AT = 9; mean SD): (E) RPM!, ()
pyruvate and (iii) lactate-based dialysates. The glucose concentration in
both pyruvate and lactate dialysates was 1.36% and the pH was between
5.4 and 5.6. The negative control (U) was a 24-hour cell culture with
neither stimulation or exposition of the cells to the test solutions. The
results indicated a moderate reduction in the endotoxin and enterotoxin-
induced cytokine synthesis when RPM! medium was compared with
pyruvate. !n contrast, a markedly significant reduction was observed (P <
0.01) for lactate-based dialysate.
pyruvate exposed cells was reduced by 4.6 to 19% when stimulated
with staphylococcal cnterotoxin, 23.1% to 29% when stimulated
with pseudomonas exotoxin, and 22% to 65% when stimulated
with LPS as compared to cells exposed to RPM!. However, after
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Fig. 4. Total cell-associated !L-1/3 and TNF-cs in peritoneal macrophages
after a 24 hour stimulation with LPS (1 nglml). Before stimulation, the
macrophages were exposed for five minutes with different solutions (N =
7; mean SD): (LII) RPM!, (III) pyruvate and (U) lactate-based dialysates.
Experimental conditions for the negative control (u), glucose concentra-
tions and the pH of the pyruvate and lactate dialysates were as described
in Figure 3. Pyruvate-based dialysate exposed macrophages generated
significantly greater levels of cytokines (P < 0.01) as compared to those
exposed to lactate-based dialysate. However, pyruvate-based dialysate
exposed peritoneal macrophages showed significantly less (P < 0.01)
cytokine synthesis as compared to the control RPMI medium.
exposure to lactate dialysate there was a much stronger reduction
of the cytokine synthesis of up to 80% when compared to RPM!
exposed cells independent of the bacterial stimulant used.
Further investigation into cytokine synthesis in peritoneal mac-
rophages stimulated with LPS as shown in Figure 4, indicated that
pyruvate-based dialysate-exposed macrophages generated signifi-
cantly greater levels of cytokines (P < 0.01; pyruvate vs. lactate)
than those exposed to lactate dialysate. Pyruvate exposed perito-
neal macrophages showed 42% (for TNF), and 29.5% (for IL-1/3)
less cytokine synthesis than the cells exposed to the control
medium (P < 0.01, pyruvate vs. control medium). In contrast,
lactate dialysate exposed macrophages showed a much more
pronounced inhibition by about 86% (for TNF), and 79% (for
IL-1/3), when compared to the cells exposed to the control
medium (P < 0.001; lactate vs. control medium).
As shown in the Figures 3 to 5, pyruvate dialysate had by far less
inhibitory effects on cytokine production than lactate, it was
therefore concluded that pyruvate maintains cell functions even at
low p1-I or in the presence of high glucose concentration. To
establish further the effect of pyruvate in relation to glucose or the
pH, a series of eight experiments were performed in the presence
and absence of pyruvate and variables of these experiments were
pyruvate (0 or 35 mmol/liter), glucose (0 or 2.5%) and pH (5.4 or
7.4). As shown in Figure 5, activated monocytes exposed to the
medium containing pyruvate at low pH and without glucose
synthesized cytokines at the same level as those cells exposed to
the medium without glucose or pyruvate. In the medium contain-
ing glucose without pyruvate at low pH, the cytokine production
was significantly reduced (P < 0.01) to about 45% of the
magnitude found in cells exposed to the corresponding medium
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Fig. 5. Effects of dialysate exposition and the variation of pynwate, glucose
and pH on the total cell-associated IL-I in peripheral blood mononuclear
cells after stimulation with staphylococcal enterotoxin B (5 ng/ml). The cells
were exposed to different solutions (N = 7; mean so) for 15 minutes,
and stimulated for 24 hours. The experiments involved 8 different
solutions by varying the pyruvate concentration (, 0; iii, 35 mmol/liter),
glucose (0 or 2.5%), and pH (5.4 or 7.4). In this design, separated blood
mononuclear cells were equally distributed to all 8 blocks of experiments.
Symbols are: (E) results obtained from the cells exposition to solutions
without pyruvate; (•) those with pyruvate (35 mmol/liter). In the solutions
lacking pyruvate, 35 mmollliter bicarbonate was present. The glucose
based solutions contained 2.5% (wt/vol). In the absence of pyruvate in the
test dialysate solutions containing glucose and at low pH there was a
significant reduction in peripheral blood mononuclear cell cytokine syn-
thesis (P < 0.01) as compared to the corresponding compositions contain-
ing pyruvate. In an acidic medium containing no added glucose or
pyruvate, cytokine generation was significantly greater (P < 0.001) than
solutions containing glucose at low pH.
containing pyruvate. The observed cytokine generation after cell
exposure to a pyruvate-free or glucose-free acidic medium was
approximately 62% higher than results obtained after cell expo-
sure to the pyruvate-free but glucose-containing acidic medium.
Finally, the medium containing pyruvate and glucose at pH 7.4
produced results similar to those observed after cell exposure to
the same medium at low pH. This therefore indicates that in the
solutions containing glucose but in the absence of pyruvate,
cytokine production was significantly reduced (P < 0.01) to
approximately 39% in activated peripheral blood mononuclear
cells.
To compare the effects of pyruvate and lactate as a function of
the glucose concentration on the peripheral monocyte IL-113
synthesis, the glucose concentration was varied in the medium
with or without pyruvate or lactate respectively. As shown in
Figure 6, in the absence of pyruvate or lactate, the increase of the
glucose concentration (0.5%, 1.5%, 2.5%, and 4%) successively
reduced the IL-ip synthesis. In the presence of lactate and the
absence of pyruvate, IL-1 synthesis was subsequently reduced to
20% at 0.5 glucose concentration, and totally inhibited at glucose
concentrations greater than 1.5% (P < 0.0001). In contrast, the
variation of glucose concentration in the presence of pyruvate or
2
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Fig. 6. Effects on IL-i f3 synthesis after the exposition of cells to variable
concentrations of pyruvate, lactate, and glucose. The cells were exposed to
different solutions (N = 7; mean so) for 15 minutes, and stimulated for
24 hours. The experiments involved 12 different solutions by varying the
concentration of pyruvate (0 or 35 mmol/liter), of lactate (0 or 35
mmol/liter), and of glucose (0, 0.5, 1.5, 2.5, and 4%). Symbols are: ()
pyruvate (0) + lactate (0); (•) pyruvate (0) + lactate (35 mmol/liter); (112)
pyruvate (35 mmol/liter) + lactate (0). For all experiments, the pH was 5.4
to 5.7. Separated blood mononuclear cells obtained from 7 donors were
equally distributed to all 12 blocks of experiments. In the absence of
pyruvate and lactate, the increase in glucose concentration significantly
reduced (P < 0.01) IL-113 synthesis.
lactate appeared to have no effect (at a glucose concentration
range of 0.5 to 1.5%) or had only a limited effect (at glucose
concentration range 2.5 to 4%; P < 0.01) on the monocyte
function.
To determine the variability in the cell response parameters as
shown in Table 1, at low pH and high glucose concentration, the
pyruvate solution indicated significantly less toxic effects on all
tested cells than the bicarbonate solution at pH 7.4 (P < 0.01). In
addition, at physiological pH the combination of bicarbonate and
pyruvate (30 mmol/liter to 10 mmol/liter, respectively) signifi-
cantly reduced (P < 0.01) cell cytotoxicity as compared to the
combination of bicarbonate with lactate.
Discussion
It has been demonstrated in previous studies that lactate-based
CAPD solutions reduce the viability, proliferation and immuno-
logical function of polymorphonuclear cells, peritoneal macro-
phages, and mesothelial cells [2—91. This study focused on the
effect of the substitution of sodium lactate with sodium pyruvate
in a new type of CAPD dialysate on the viability, proliferation and
immunological functions of leukocytes. The findings indicate that
pyruvate based dialysate minimizes the cytotoxic effects of pen-
toncal (macrophages) and peripheral blood leukocytes (granulo-
cytes and monocytes) after exposure to conventional racemic
lactate dialysate, pyruvate dialysate, and RPM! as the control
neutral solution. The parameters investigated were 02 produc-
tion, chemotactic response, cytokine-mRNA detection, and cyto-
kine synthesis after stimulation. We have found that cells pre-
incubated with pyruvate dialysate and RPMI exhibited the same
cytokine-mRNA signals after one to two hours stimulation with
endotoxin. Accordingly cytokine generation after 24 hours stim-
ulation was not suppressed in the pyruvate dialysate-exposed cells.
In contrast, conventional lactate dialysate totally inhibited the
cytokine signal and protein synthesis. Furthermore, the chemo-
taxis of granulocytes and the °2 generation in macrophages and
granulocytes after exposure to pyruvate dialysate was comparable
to that observed after RPMI exposure, whereas a complete
inhibition of these parameters was found after exposure to lactate
dialysate. To substantiate the role of pyruvate in maintaining
leukocyte cell functions, the following aspects were demonstrated:
(1) glucose has toxic effects on leukocytes independent of pH and
lactate, (2) lactate enhances the glucose cytotoxicity, which is
neutralized by pyruvate.
According to the metabolism and transport of dialysate chem-
icals in the peritoneum, the half life of lactate anions in the
peritoneum does not exceed 30 minutes. The time relating the
dialysate-peritoneum exposure was considered an important as-
pect of the test procedures used to determine the immunosup-
pression of the tested cells. Consequently, in the design of our
experiments the exposure to lactate or pyruvate was short (5 and
15 mm, respectively) and was performed before stimulation of the
tested cells. During stimulation, RPM! was used as the neutral
medium to avoid further exposure of cells to high glucose and
lactate concentrations. The cytotoxicity of glucose and lactate and
the beneficial effects of pyruvate on cell function was maintained
during stimulation of up to 24 hours. The cytotoxic properties of
lactate-based CAPD solutions have been attributed to: (1) high
glucose concentrations [10]; (2) to the acidity of the dialysate [3];
(3) to the lactate anions being in racemic mixtures of both D- and
L-forms of lactate [29, 30].
High glucose concentration has been shown to induce cell-
respiratory inhibition in tumour cells [31, 32] and in guinea pig
spermatozoa [33]. A long time of exposure (5 days) with a glucose
concentration of 30 mmol/liter has been shown in the past to
inhibit endothelial cell proliferation and DNA synthesis [11, 12].
Sehagiri and Bavister [34] demonstrated an inhibition of hamster
blastocyte transformation in culture media containing 5 mmol/
liter glucose. With respect to peritoneal dialysate toxicity, Bre-
borowitz, Rodela and Oreopoulos [101 observed a reduced me-
sothelial cell proliferation at a glucose concentration of 60 to 90
mmol/liter. The findings in this study have indicated that the
media with high glucose content elicits greater inhibition of
leukocyte functions compared to the media with lower glucose
concentration (Fig. 5). It is possible that the biochemical mecha-
nisms of glucose toxicity in CAPD may be related to the Crabtree
effect. The Crabtree effect has been proposed to be a manifesta-
tion of respiratory inhibition in the presence of high glucose
concentration or other hexose [32]. This effect includes the
contraction of mitochondnia and a decrease in the rate of glucose
utilization occurring at the time of respiratory inhibition. Accord-
ing to Koobs [32], this effect does not inhibit glycolysis, but it may
cause inadequate energy generation presumably by decreasing the
availability of nicotinamide adenine dinucleotide and/or oxidative
potential, which may subsequently depress lactate oxidation to
pyruvate. In this context, previous studies have found that the
glycolytic pathway provides less ATP in hamster embryos exposed
to glucose-rich media [33]. So far, the Crabtree effect has been
described only in transformed cells [32, 33], guinea pig sperma-
tozoa [35] and in hamster blastocytes [34]. This study has dem-
onstrated that the Crabtree effect may also be involved in glucose
toxicity on leukocytes.
The use of racemic mixture of lactate anions in conventional
CAPD dialysate has been adapted from the parenteral fluid
composition known as lactated Ringer's solution developed in the
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Table 1. Means (± SD; N = 7) of zymosan stimulated 02 production (PBMC, peritoneal macrophages) and granulocytes and endotoxin
stimulated IL-ill (PBMC) after exposure to different peritoneal solutions with high glucose concentration (3.86%): lactate (35 mmol/liter; pH 5.2),
pyruvate (35 mmol/liter; pH 5.2), bicarbonate (35 mmol/liter; pH 7.4), and combined lactate-bicarbonate (10—30 mmol/liter; pH 7.4) or pyruvate-
bicarbonate (10—35 mmol/liter; pH 7.4)
Lactate Pyruvate
(10 mmol/liter) (10 mmol/liter)
Lactate Pyruvate Bicarbonate bicarbonate bicarbonate
Control (35 mmol/liter) (35 mmol/liter) (35 mmol/liter) (30 mmol/liter) (30 mmol/liter)
(RPMI) pH 5.2 pH 5.2 pH 7.4 pH 7.4 pH 7.4
PBMC (O2) 1.95 0.22 0.21 0.07 1.45 0.27 1.17 0.21 1.17 0.11 1.88 0.23
Peritoneal macrophages (O2) 1.81 0.17 0.09 0.01 1.21 0.22 0.88 0.20 0.82 0.18 1.76 0.19
Granulocytes (02) 2.26 0.25 0.06 0.01 2.07 0.18 1.37 0.21 0.97 0.18 2.13 0.31
PBMC (IL-ill) 7.79 2.1 0.35 0.12 5.9 1.3 4.48 0.8 3.38 0.65 6.36 2.1
Peritoneal macrophages (IL-lp) 1.9 0.35 0.21 0.12 1.15 0.24 0.87 0.21 0.83 0.27 1.7 0.18
1930s [36]. The physiological lactate produced by cellular metab-
olism is L-lactate, with D-lactate present only in trace concentra-
tions [371. In peritoneal dialysis, the cytotoxicity of lactate-based
peritoneal dialysate can be partially avoided by bicarbonate-based
CAPD solutions [221. However, the mechanism causing the
cytotoxicity of lactate anions has not yet been fully explained.
Peritoneal leukocytes utilize lactate as energy substrate during the
ingestion of invading microorganisms and senescent host cells
[38], and take up L-lactate preferentially in an acidic environment
via a monocarboxylate transporter [39]. It might be speculated
that lactate toxicity in CAPD is linked to the same mechanism as
glucose toxicity, since pyruvate eliminates both glucose and lactate
cytotoxicity. On the other hand, it is possible that lactate oxidation
may have been blocked, leading to an insufficient energy produc-
tion via glycolytic metabolic pathway as a result of the Crabtree
effect initiated by the high glucose concentrations in the dialysate.
Pyruvate seems to be effective as an alternative energy substrate
necessary for leukocyte activation. In this context Seshagiri and
Bavister [34] demonstrated previously that only the addition of
pyruvate to glucose-containing medium increased blastocyte de-
velopment, while lactate did not. Pyruvate alone supported devel-
opment of hamster eight-cell embryos, whether or not the media
contained lactate [34j. It has been demonstrated in this study that
in the presence of glucose, leukocyte activation increases when
pyruvate is present in the dialysate, but not in the presence of
lactate. The new pyruvate-containing dialysate might maintain
leukocyte functions by providing the cells with an energy source
not influenced by the Crabtree effect. We speculate that when
pyruvate is used in the dialysate, the glucose-induced respiratory
inhibition is reduced, while the oxidation of pyruvate is not
diminished as compared to lactatc by glycolysis, and because
pyruvate dehydrogenase activity is enhanced rather than de-
pressed by phosphate ions (Pi) deficiency or reduced ATP/ADP.
Such observations relating the interaction between the Crabtree
effect and pyruvate were made by Linn and Reed in 1969 by using
mitochondria from normal tissues. The role of the Crabtree effect
in CAPD dialysate toxicity needs to be verified in leukocytes and
peritoneal cells by measurements of respiration and the analysis
of certain key metabolites.
The clinical applicability of a peritoneal dialysate depends on its
capacity to correct metabolic acidosis in uremic patients. In
conventional dialysate this is achieved by the 35 mmol/liter
sodium lactate which is metabolized to bicarbonate in the liver.
Sodium pyruvate (35 mmollliter) should efficiently correct meta-
bolic acidosis since the half-life of pyruvate in vivo is not longer
than 5 to 15 minutes because of its rapid hepatic conversion to
lactate. In an intravenous pyruvate loading test applied in healthy
subjects by van Erven et al [40], it was demonstrated that 500
mg/kg body wt of sodium pyruvate administered in a period of 10
minutes was completely metabolized in 60 minutes. The in vitro
study, therefore, has provided further information that supports
the view that sodium pyruvate-based peritoneal dialysis could be
clinically applicable. Sodium pyruvate in aqueous solutions is
stable, easily sterilizable, and can be prepared during the clinical
utilization without difficulties. In severe hepatic disfunction, how-
ever, it is important that pyruvate or lactate based dialysis are best
be avoided in view of the depressed hepatic metabolism.
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Appendix
Abbreviations are: RPMI, Roosevelt Park Memorial Institute; fMLP,
N-Formyl-Met-Leu-Phe (a chemotactic peptide); M-MLV, Moloney mu-
rine leukemia virus; DTT', dithiolthreitol (a component of the transcrip-
tion buffer); dNTPs, deoxynucleotide triphosphates for enzymatic ampli-
fication of synthesized DNA or RNA (dATP, dCTP, dGTP, dTTP,
dUTP); LAL, limulus amebocyte lysate; LPS, lipopolysaccharides (endo-
toxin component); Pi, phosphate ions; PCR, polymerase chain reaction
(procedure for amplification and detection of DNAJRNA sequences).
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